Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FCSC

Fibrocell Science (FCSC) Stock Price, News & Analysis

Fibrocell Science logo

About Fibrocell Science Stock (NASDAQ:FCSC)

Advanced Chart

Key Stats

Today's Range
$3.00
$3.00
50-Day Range
$3.00
$3.00
52-Week Range
$1.45
$3.28
Volume
N/A
Average Volume
78,673 shs
Market Capitalization
$29.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FCSC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fibrocell Science and its competitors with MarketBeat's FREE daily newsletter.

FCSC Stock News Headlines

Best Data Science Bootcamps Online In 2024
Science & Tech News
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Revolution we predicted has arrived." In fact, I believe these robots could impact 65 million Americans lives — by August of this year.
Oramed Pharmaceuticals
See More Headlines

FCSC Stock Analysis - Frequently Asked Questions

Fibrocell Science Inc (NASDAQ:FCSC) announced its quarterly earnings data on Wednesday, August, 14th. The company reported $1.12 EPS for the quarter, beating analysts' consensus estimates of ($0.18) by $1.30. The firm earned $21.79 million during the quarter.

Fibrocell Science's stock reverse split on the morning of Friday, May 25th 2018.The 1-5 reverse split was announced on Thursday, May 24th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 24th 2018. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fibrocell Science investors own include Carlyle Group (CG), Celldex Therapeutics (CLDX), Neos Therapeutics (NEOS), Amarin (AMRN), OPKO Health (OPK), NextTrip (NTRP) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
8/14/2019
Today
7/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:FCSC
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
30.00
P/E Growth
N/A
Net Income
-$10.28 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$350 thousand
Price / Cash Flow
N/A
Book Value
$0.98 per share
Price / Book
3.06

Miscellaneous

Free Float
N/A
Market Cap
$29.28 million
Optionable
Optionable
Beta
1.67
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:FCSC) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners